Idéal Investisseur
Français English
CAC 40 : Market open
8 154,59 pts
-0.04%


Last updated : 27/04/2026 - 10h16

Stock GENOWAY (FR0004053510)

Sector : Pharmaceuticals & Biotechnology – Indices : EN GROWTH ALLSHARE, NEXT BIOTECH

Price 2,50 €
Daily change 0,00 %
1 week 0,00 %
1 month 0,00 %
1 year -11,03 %

Last update : 27/04/2026 at 09:00:06 – Source: Euronext

Assurance vie

Market summary

As of 27/04/2026, stock GENOWAY trades at 2,50 € , with a change of 0,00 % , and a market cap of 32 M€. Reference period : année 2025.

Open0,00 €
Previous close2,50 €
Volume10
Market cap32 M€
P/EN/A
Dividend / shareN/A
Float turnover0,00 %
MarketEuronext PARIS
Eligible PEA

Price and moving averages

Technical analysis GENOWAY

50-day moving average2,44 €2.46 % (above) Pivot2,47 €
Support level2,18 €-12.80 % Resistance level2,53 €+1.20 %
1-month volatility12,40 % Annualised volatility42,94 %
RSI (14d)56 Neutral Stochastic signal (14d)Neutre
ATR (14d)0,09 Low volatility CMF (21d)0,26 Moderate buying pressure
Bollinger bands (20d) Neutral OBV (21d) Neutral (OBV stable)

Analyst consensus and recommendations

Insufficient data.

No analyst recommendation available.

Stock history and statistics

IPO dateMay 04, 2007
52-week high2,79 €52-week low2,18 €
All-time high7,75 €All-time low0,84 €
1-year volatility42,94 %Beta0,02

Financial calendar — GENOWAY

-

Recent news — GENOWAY

genOway announces the opening of its first two distribution franchises in Canada and Australia, marking a key milestone in its strategic plan ROUTE50+…

GenOway has emerged from a year of forced transformation. While its revenue declined by 5% in 2025 in a cautious economic environment, the Lyon-based …

GenOway announces the establishment of GenOway Japan, a wholly-owned subsidiary aimed at promoting and developing the sale of preclinical models in im…

Latest earnings

Annuels année 2025
Revenue 21,0 M€

Guidance

Revenue outlook

CA visé en 2026 supérieur à 23 M€

Management commentary

Croissance organique visée >10% en 2026 et EBITDA >15% sur l'ensemble du plan ROUTE50+ (ROUTE50+DATA)

Analyses on GENOWAY stock

No analysis has been published on this stock yet.

Frequently asked questions about GENOWAY stock

What does the recent price action of GENOWAY stock show?

GENOWAY stock is currently trading around 2,50 €, flat and flat over one week.

Is GENOWAY stock in a support or resistance zone?

Technical levels help place the stock. Support: 2,18 €. Resistance: 2,53 €.

How should the current volatility of GENOWAY stock be interpreted?

Volatility is around 42,94%.

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA
BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit